Animal healthcare pharma producer ECO Animal Health Group announced receiving Health Ministry approval to sell Aivlosin in Egypt. The medication is used “for the treatment of infections caused by Mycoplasma in poultry laying eggs for human consumption.” ECO Chairman Peter Lawrence said “Egypt is the second most important egg producing country in the Middle East and is ranked just outside the global top 20 for commercial layers.”
More from Enterprise
Our friends at EFG Hermes and Beltone pick up fresh accolades, along with CIB
EFG Hermes retained the top corporate access spot on Extel’s…
Granite is about to test whether Egypt’s funds still need administrators
The asset manager and blockchain builder Tarmiiz have entered the…
Inside the retail wave reshaping EGX
Individuals are setting EGX prices day to day, trading on…
Egyptian-UK fintech Zeal raises USD 10 mn to back expansion plans
The London-based, Egyptian-founded fintech is preparing to activate its loyalty…